Navigation Links
As Tylenol Lawsuits Mount, Bernstein Liebhard LLP Notes Study Questioning Some Benefits Purportedly Associated with Acetaminophen

New York, NY (PRWEB) July 27, 2014

As Tylenol lawsuits ( involving liver injuries continue to move forward in federal court, Bernstein Liebhard LLP notes that a new study is questioning one of the benefits purportedly associated with acetaminophen, the active ingredient in Tylenol-brand over-the-counter medications. The research, which appears in the The Lancet, looked at 1,643 people with acute low-back pain, all of whom were given either acetaminophen or a placebo for their pain. After three-months of treatment, roughly 2/3 of the subjects reported satisfactory results regardless of whether they were taking acetaminophen or a placebo. The researchers were unable to discern any variations in terms of pain, recovery time, function, disability, symptom change, sleep or quality of life.*

“Dozens of people have filed Tylenol lawsuits alleging the acetaminophen in these medications caused serious liver injuries. This study is just a reminder that despite its near-ubiquitous presence in most households, the benefits of acetaminophen may not always outweigh its risks,” says Bernstein Liebhard LLP, a nationwide law firm representing the victims of defective drugs and medical devices. The Firm is offering free legal reviews to consumers who were allegedly harmed by a Tylenol-brand over-the-counter medication.

Tylenol Liver Damage Litigation
According to the U.S. Food & Drug Administration (FDA), acetaminophen, the active ingredient in Tylenol products, was the leading cause of acute liver failure in the U.S. between 1998 and 2003.* The Philadelphia Inquirer recently reported that 78,000 people require emergency room care every year due to toxic reactions to acetaminophen. Such injuries also result in about 33,000 hospitalizations every year.**

In April, the FDA announced that prescription drugs containing more than 325 milligrams of acetaminophen were no longer considered safe and were being voluntarily removed from the market. *** However, according to a report, over-the-counter Extra Strength Tylenol caplets each contain 500 mg of acetaminophen. Last year, McNeil Consumer Healthcare announced that it would add new, more prominent warnings regarding the risk of liver damage to the labels of Tylenol-brand medication.****

According to court documents, at least 147 Tylenol liver damage claims are currently pending in the litigation underway in the Eastern District of Pennsylvania. All of the lawsuits were filed on behalf of individuals who allegedly suffered injuries due to acetaminophen in Tylenol products. In many cases, plaintiffs claim that liver damage occurred even though the drugs were used in accordance with label directions, and resulted in hospitalization, the need for liver transplantation or death.

Individuals who suffered serious liver damage allegedly related to the acetaminophen in a Tylenol medication may be entitled to compensation for their injury-related damages. To learn more about the potential link between Tylenol and liver damage, please visit Bernstein Liebhard LLP's website. Free, confidential and no-obligation case reviews are available by calling 800-511-5092.

*, The Lancet, July 24, 2014
**, FDA, 2009
***, Philadelphia Inquirer, February 17, 2014
****, LA Times, April 28, 2014
*****,, August 29, 2013

About Bernstein Liebhard LLP
Bernstein Liebhard LLP is a New York-based law firm exclusively representing injured persons in complex individual and class action lawsuits nationwide since 1993. As a national law firm, Bernstein Liebhard LLP possesses all of the legal and financial resources required to successfully challenge billion dollar pharmaceutical and medical device companies. As a result, our attorneys and legal staff have been able to recover more than $3 billion on behalf of our clients. The Firm has been named by The National Law Journal to the Plaintiffs Hot List, recognizing the top plaintiffs firms in the country, for the past 12 consecutive years. Bernstein Liebhard LLP is the only firm in the country to be named to this prestigious list every year since it was first published in 2003.

Bernstein Liebhard LLP
10 East 40th Street
New York, New York 10016

ATTORNEY ADVERTISING. © 2014 Bernstein Liebhard LLP. The law firm responsible for this advertisement is Bernstein Liebhard LLP, 10 East 40th Street, New York, New York 10016, 800-511-5092. Prior results do not guarantee or predict a similar outcome with respect to any future matter.

Contact Information:
Felecia L. Stern, Esq.
Bernstein Liebhard LLP

Read the full story at

Source: PRWeb
Copyright©2014 Vocus, Inc.
All rights reserved

Related medicine news :

1. Tylenol Lawsuit News: U.S. District Judge Overseeing Federal Tylenol Liver Damage Litigation Orders Deposition of Former McNeil President, Bernstein Liebhard LLP Reports
2. As Tylenol Lawsuits Mount, Bernstein Liebhard LLP Notes New Study Finding that Acetaminophen Combined With Alcohol May Increase Risk for Kidney Damage
3. Tylenol Lawsuit News: Bernstein Liebhard LLP Notes Release of Study Finding Tylenol Use in Pregnancy May Affect Child Development
4. Tylenol Liver Problem Allegations Help: Resource4thePeople Comments on Legal Developments
5. Tylenol Lawsuits Move Forward, as Bernstein Liebhard LLP Notes Upcoming Status Conference in Federal Tylenol Litigation
6. Tylenol Lawsuit News: Bernstein Liebhard LLP Notes Filing of New Claim Alleging Use of Tylenol Caused Liver Damage
7. Tylenol Liver Damage Allegations Lawyer Help: Resource4thePeople Reports Judge Outlines Procedures for Bellwether Trials
8. Injury Law Firm Comments on the FDA Consumer Update Warning about Tylenol Side Effects like SJS
9. Tylenol Lawsuit News: New Jersey Supreme Court Refuses Multicounty Case Consolidation, Rottenstein Law Group LLP Reports
10. Latest Tylenol Liver Failure Lawsuit Allegations Report: Resource4thePeople Urges Consumers to Fully Inform Themselves about Liver Disease Danger Possibility
11. Rottenstein Law Group LLP Announces New Tylenol Lawsuit Center
Post Your Comments:
(Date:11/30/2015)... ... November 30, 2015 , ... ... magazines and websites specializing in independent living, assisted living and all other retirement ... Alzheimer’s awareness and research remains a top priority. , So ...
(Date:11/30/2015)... ... November 30, 2015 , ... Holcomb – Kreithen Plastic ... surgery practices in Florida, is proud to announce that Dr. Joshua Kreithen, one ... Ethicon Inc., a Johnson & Johnson Company. , Ethicon is a global medical ...
(Date:11/30/2015)... ... November 30, 2015 , ... Sikka Software announced today that ... Their Ecosystem empowers dentists to make complex business decisions by providing the tools and ... a free fee survey with 10 procedures customized by zip code. , The ...
(Date:11/30/2015)... ... November 30, 2015 , ... Vasont Systems, ... Vasont Universal Integrator (VUI) extension unites with Syncro Soft’s latest software update, oXygen ... a continuous process with the latest release of oXygen® XML editor and the ...
(Date:11/30/2015)... ... 30, 2015 , ... Healthjump, Inc. announced that it has ... consulting, development and support company. The purchase will expand the capability to serve ... extend the services currently provided by Healthjump. , Through this purchase, ...
Breaking Medicine News(10 mins):
(Date:11/30/2015)... Wash. , Nov. 30, 2015  Precision ... Post-Processing services, is pleased to announce a dramatic ... medical imaging services. Building on its ISO-9001:2008 certification ... and implemented comprehensive Core Lab protocols and procedures. ... variety of research activities.  Their Core Lab services ...
(Date:11/30/2015)... , November 30, 2015 Mexico Healthcare ... and Life Sciences Report 2015 . --> Pharmaboardroom releases ... . Latin America , a country of ... , a country of over 122 million people. --> ... healthcare, pharmaceuticals, or life sciences insights into the second largest pharma ...
(Date:11/30/2015)... TEL AVIV, Israel , November 30, 2015 /PRNewswire/ ... EMITF ) ("Elbit" or the "Company") announced today that it ... Ministry of Food and Drug Safety (MFDS) has approved ... behavioral disorders. --> --> ... presenting a non-invasive treatment alternative that combines two technologies: ...
Breaking Medicine Technology: